|
CN110117257A
|
|
A kind of P2Y12 receptor antagonist, preparation method and its usage containing guanidine radicals
|
|
WO2017148406A1
|
|
Pyrimidine seven-membered-ring compounds, preparation method therefor, pharmaceutical composition thereof, and uses thereof
|
|
CN105130899A
|
|
Synthetic method for eslicarbazepine acetate
|
|
CN104840440A
|
|
(S)-metroprolol succinate sustained release tablet and preparation method thereof
|
|
CN105985232A
|
|
Ferric citrate with high iron content and preparation method therefor
|
|
CN105985283A
|
|
Synthesis method for Pimeprofen
|
|
US2016052873A1
|
|
intermediate used for preparing tapentadol or analogues thereof
|
|
CN104086450A
|
|
Crystal form delta of metoprolol succinate, and preparation method and application thereof
|
|
CN103980134A
|
|
Preparation method of succinic acid S-metoprolol
|
|
CN103980249A
|
|
Method for refining alogliptin benzoate
|
|
CN103626850A
|
|
Polypeptide with cell penetration function and application of polypeptide to medicament delivery
|
|
CN103113350A
|
|
Novel crystal form of R-rabeprazole sodium hydrate, preparation method and application thereof
|
|
CN102584897A
|
|
Refining method for minodronic acid
|
|
CN102557851A
|
|
New method for synthesizing tapentadol hydrochloride and analogue of tapentadol hydrochloride
|
|
WO2013016840A1
|
|
Novel intermediate used for preparing tapentadol or analogues thereof
|
|
CN102050766A
|
|
Synthesis method for amosulalol hydrochloride
|
